Omeros Stock Plan Amendment
Omeros Corporation granted a performance-based stock option award to CEO Gregory A. Demopulos for up to 500,000 shares at an exercise price of $17.88. The award vests across four tranches tied to stock-price hurdles ranging from $25.00 to $40.00 per share and requires continued service over a four-year period. The grant is intended to incentivize long-term shareholder value creation following the company's recent strategic milestones, including FDA approval of YARTEMLEA.
- Term
- 5 years